![]() |
市場調查報告書
商品編碼
2087415
翻新醫療圖像設備市場:2026-2032年全球市場預測(依產品類型、翻新流程、安裝方式、應用領域、最終用戶和通路分類)Refurbished Medical Imaging Equipment Market by Product Type, Refurbishment Process, Installation Type, Application, End User, Distribution Channel - Global Forecast 2026-2032 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計到 2032 年,翻新醫療圖像設備市場規模將達到 68.8 億美元,複合年成長率為 5.31%。
| 主要市場統計數據 | |
|---|---|
| 基準年 2025 | 47.9億美元 |
| 預計年份:2026年 | 50.3億美元 |
| 預測年份:2032年 | 68.8億美元 |
| 複合年成長率 (%) | 5.31% |
由於醫院、影像中心、門診診所和公共衛生系統都在尋求以比新設備更低的資本投資成本可靠地使用 CT、MRI、超音波、X 光、乳房X光攝影、核子醫學和 C 臂系統,翻新醫療圖像設備市場正在成為擴大醫療保健基礎設施的戰略支柱。
這項需求是由一些已證實的結構性趨勢所驅動的,包括慢性病負擔加重、人口老化、篩檢計畫的擴展以及影像檢查服務取得方面持續存在的不平等現象,世界衛生組織(WHO)和經濟合作暨發展組織(OECD)等公共衛生機構均有相關報告。翻新設備能夠幫助醫療機構拓展診斷範圍,同時透過延長設備使用壽命、組件再利用和減少電子廢棄物,協助實現永續性目標。
這一領域正從以價格主導的設備二手交易轉向由原始設備製造商 (OEM)、專業翻新商、獨立服務機構和醫院採購網路支持的、經過認證且品管的翻新項目。買家越來越重視拆卸記錄、零件更換、軟體檢驗、輻射安全檢查、影像品質測試、保固範圍和服務可用性。
人工智慧 (AI) 透過提高影像擷取速度、重建品質、最佳化工作流程、改善分流和設備維護,為翻新醫療圖像設備創造累積價值。當軟體檢驗、網路安全措施和相關監管批准到位後,AI 驅動的重建技術可以幫助相容的 CT 和 MRI 平台提高影像品質並縮短掃描時間。
在亞太地區,龐大的患者群體、不斷擴展的醫院網路以及先進影像設備獲取方面的不均衡,促使人們對經濟高效的CT、MRI、超音波和數位X光系統越來越感興趣,從而導致對翻新醫療圖像設備的需求強勁。中國和印度的特點是規模龐大、都市區醫療資源分配不均以及對公共和私營醫療基礎設施的巨大需求,而日本、韓國和澳洲則更加重視品質保證、合規性、服務可靠性和生命週期管理。在東協地區,進口限制、保險報銷系統的發展、生物醫學工程能力以及訓練有素的服務合作夥伴的可用性都會影響設備的採用率。
東協市場受益於私人醫療網路的擴張、非傳染性疾病篩檢需求的成長以及對診斷能力的持續投資。然而,實施的成功取決於進口政策的清晰度、生物醫學工程能力、本地服務網路以及替換零件的供應。在海灣合作理事會(GCC)國家,對高品質的翻新磁振造影(MRI)、電腦斷層掃描(CT)、數位X光和介入性影像設備的需求旺盛。這些國家的醫療服務提供者希望在滿足認證標準、病人安全要求以及自身作為高品質醫療服務提供者定位的同時,更快地升級設備。
在美國,大規模醫院系統、門診影像中心、日間手術網路以及成熟的認證翻新設備分銷管道是推動需求的主要因素,買家優先考慮FDA合規性、運轉率保證、網路安全措施、輻射安全和服務合約。在加拿大,省級政府採購、偏遠農村地區的醫療需求以及成本控制推動了設備的穩定普及。墨西哥和巴西則依靠翻新醫療圖像設備來擴大公立和私立機構的診斷能力,同時也要應對進口流程的複雜性、預算管理以及對可靠技術支援的需求。
產業領導者應透過透明的再生設備文件、檢驗的影像品質測試、有保障的服務模式以及具備網路安全措施的軟體管理來建立信任。清晰的零件更換、校準、劑量性能、預防性保養、安裝合格和監管狀態記錄對於說服醫院採購委員會和影像中心營運商至關重要。
本執行摘要採用系統化的二手調查方法編寫,重點關注檢驗的公開資訊來源、監管文件、行業標準、醫療基礎設施指標和採購趨勢。輸入資訊包括醫療設備監管指南、醫療系統報告、再製造品管規範、標準中的安全考量、循環經濟參考資料以及已記錄的區域醫療投資模式。
翻新醫療圖像設備正從單純的預算替代方案轉變為實現診斷、設備可靠性和永續醫療採購的策略性手段。推動這一市場發展的因素包括影像需求的成長、資金限制、對循環經濟日益重視以及翻新品質標準的提高。
The Refurbished Medical Imaging Equipment Market is projected to grow by USD 6.88 billion at a CAGR of 5.31% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 4.79 billion |
| Estimated Year [2026] | USD 5.03 billion |
| Forecast Year [2032] | USD 6.88 billion |
| CAGR (%) | 5.31% |
The refurbished medical imaging equipment market is becoming a strategic pillar of healthcare capacity expansion as hospitals, diagnostic imaging centers, ambulatory care providers, and public health systems seek reliable access to CT, MRI, ultrasound, X-ray, mammography, nuclear medicine, and C-arm systems at lower capital cost than new equipment.
Demand is supported by verified structural trends, including rising chronic disease burden, aging populations, expanding screening programs, and persistent imaging access gaps documented by public health agencies such as the World Health Organization and OECD. Refurbished systems help providers extend diagnostic reach while aligning with sustainability goals through equipment life-cycle extension, parts reuse, and reduced electronic waste.
The landscape is shifting from price-led equipment resale to certified, quality-controlled refurbishment programs backed by original equipment manufacturers, specialized refurbishers, independent service organizations, and hospital procurement networks. Buyers increasingly prioritize documented de-installation, component replacement, software validation, radiation safety checks, image-quality testing, warranty coverage, and service availability.
Regulatory scrutiny, cybersecurity requirements, interoperability needs, and uptime expectations are transforming the market. Health systems now evaluate refurbished imaging assets through total cost of ownership, clinical use case, service continuity, and compliance with standards such as U.S. FDA medical device requirements, European medical device rules, IEC safety standards, DICOM compatibility, and local radiation protection regulations.
Artificial intelligence is creating cumulative value across refurbished medical imaging equipment by improving acquisition speed, reconstruction quality, workflow orchestration, triage, and equipment maintenance. AI-enabled reconstruction can help compatible CT and MRI platforms improve image quality or reduce scan times when software validation, cybersecurity controls, and applicable regulatory clearance are in place.
AI is also influencing refurbishment operations. Predictive maintenance models, remote diagnostics, automated quality assurance, and parts-demand forecasting support better uptime and lower service risk. However, leaders must verify software approvals, clinical validation, data governance, model performance, hardware compatibility, and integration with PACS, RIS, and electronic health record workflows before deployment in clinical environments.
Asia-Pacific is experiencing strong demand for refurbished medical imaging equipment as high patient volumes, hospital expansion, and uneven access to advanced imaging drive interest in cost-effective CT, MRI, ultrasound, and digital radiography systems. China and India are shaped by scale, urban-rural access gaps, and large public and private healthcare infrastructure needs, while Japan, South Korea, and Australia place stronger emphasis on quality assurance, compliance, service reliability, and lifecycle management. Across ASEAN, adoption is influenced by import rules, reimbursement development, biomedical engineering capacity, and the availability of trained service partners.
North America remains a mature and compliance-driven environment where replacement cycles, outpatient imaging growth, certified refurbishment, and strict expectations for uptime, service documentation, cybersecurity, and radiation safety support continued adoption. Europe emphasizes quality assurance, circular economy principles, traceability, and alignment with medical device and environmental rules, making documented refurbishment processes essential. Latin America uses refurbished systems to expand diagnostic access amid budget constraints, currency pressures, and uneven public-sector capital investment, with Brazil and Mexico serving as major adoption centers. In the Middle East, private hospital investment, specialty care development, and medical tourism support demand for premium refurbished systems, whereas Africa's opportunity is tied to infrastructure readiness, reliable power supply, financing, workforce training, and dependable maintenance partnerships.
ASEAN markets benefit from expanding private healthcare networks, rising noncommunicable disease screening needs, and continued investment in diagnostic capacity, but adoption depends on import policy clarity, biomedical engineering capability, local service coverage, and access to replacement parts. The GCC shows demand for high-quality refurbished MRI, CT, digital radiography, and interventional imaging where providers seek faster capacity additions while maintaining accreditation standards, patient safety requirements, and premium care positioning.
The European Union's circular economy agenda and medical device regulatory framework encourage traceable refurbishment with rigorous quality management, safety documentation, and post-installation accountability. BRICS countries represent a large access-driven opportunity because public health systems and private providers need scalable imaging capacity across large populations and geographically diverse care settings. G7 markets are shaped by replacement cycles, advanced service expectations, cybersecurity requirements, lifecycle cost evaluation, and clinical performance validation, while NATO countries increasingly emphasize resilient healthcare infrastructure, supply chain security, and continuity of critical diagnostic assets.
The United States leads demand through large hospital systems, outpatient imaging centers, ambulatory surgery networks, and established certified refurbishment channels, with buyers emphasizing FDA compliance, uptime guarantees, cybersecurity readiness, radiation safety, and service contracts. Canada shows steady adoption where provincial procurement, rural and remote access needs, and cost control intersect. Mexico and Brazil rely on refurbished imaging to expand private and public diagnostic capacity while managing import complexity, budget discipline, and the need for dependable technical support.
In Europe, the United Kingdom, Germany, France, Italy, and Spain prioritize traceability, radiation protection, image-quality validation, and service quality, with Germany and France showing strong demand for certified premium systems used in hospital and specialist diagnostic settings. Russia's market is influenced by localization policies, sanctions exposure, and supply chain constraints that affect equipment availability and service continuity. In Asia-Pacific, China and India represent scale-driven opportunities supported by expanding healthcare infrastructure and growing imaging demand, Japan and South Korea emphasize high performance, quality assurance, and advanced workflow integration, and Australia prioritizes compliance, service reliability, regional access, and lifecycle value.
Industry leaders should build trust through transparent refurbishment documentation, validated image-quality testing, warranty-backed service models, and cybersecurity-ready software management. Clear records for component replacement, calibration, dose performance, preventive maintenance, installation qualification, and regulatory status are essential to win hospital procurement committees and imaging center operators.
Suppliers should prioritize modular service networks, remote diagnostics, parts availability, user training, and financing options such as leasing, managed equipment services, and trade-in programs. Buyers should align equipment selection with clinical workload, reimbursement environment, facility infrastructure, radiologist workflow, radiation protection requirements, and long-term service coverage rather than focusing only on purchase price.
This executive summary is developed using a structured secondary-research methodology focused on verified public sources, regulatory references, industry standards, healthcare infrastructure indicators, and procurement trends. Inputs include medical device regulatory guidance, health system reports, refurbishment quality practices, standards-based safety considerations, circular economy references, and documented regional healthcare investment patterns.
The analysis triangulates demand drivers, technology shifts, regional adoption factors, and operational risks across equipment categories including CT, MRI, ultrasound, X-ray, mammography, C-arms, and nuclear imaging. Findings are framed qualitatively where consistent public data is available and avoid unsupported market-size, market-share, or forecast claims, ensuring relevance for strategic planning, SEO visibility, and executive decision-making.
Refurbished medical imaging equipment is moving from a budget alternative to a strategic enabler of diagnostic access, capacity resilience, and sustainable healthcare procurement. The market is supported by rising imaging demand, capital constraints, circular economy priorities, and improved refurbishment quality standards.
Organizations that combine regulatory compliance, certified quality assurance, AI-ready workflows, strong service infrastructure, and flexible financing are best positioned to strengthen adoption. As healthcare systems balance cost, access, and clinical performance, refurbished CT, MRI, ultrasound, X-ray, mammography, C-arm, and nuclear imaging platforms will remain central to global diagnostic expansion.